Home Antibody All anti-DPAGT1 antibodies
Anti-DPAGT1 Antibody Polyclonal
Also for DPAGT1 (NM_001382)
|DPAGT1 antibody was raised against a 17 amino acid synthetic peptide near the amino terminus of human DPAGT1.|
|WB, IHC, IF
||WB: 1 ug/ml, IHC: 2.5 ug/ml, IF: 20 ug/ml
|DPAGT1 Antibody is supplied in PBS containing 0.02% sodium azide.|
|DPAGT1 Antibody is affinity chromatography purified via peptide column.
|Homo sapiens dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase) (DPAGT1)|
|ALG7; CDG-Ij; CDG1J; CMSTA2; D11S366; DGPT; DPAGT; DPAGT2; G1PT; GPT; UAGT; UGAT|
|DPAGT1 Antibody: The UDP-N-acetylglucosamine-dolichyl-phosphate N-acetyl-glucosaminephosphotransferase (DPAGT1) is an enzyme that catalyzes the first step in the dolichol-linked oligosaccharide pathway for glycoprotein biosynthesis. Mutations in this integral endoplasmic reticulum (ER) membrane protein enzyme belongs to the glycosyltransferase family 4 results in the congenital disorder of glycosylation type Ij with symptoms such as severe hypotonia, medically intractable seizures, mental retardation, microcephaly, and exotropia. Recent experiments have shown that DPAGT1 is a target of the Wnt/beta-catenin signaling pathway, with Wnt3a inducing higher DPAGT1 mRNA expression. |
* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western blot analysis of DPAGT1 in mouse kidney tissue lysate with DPAGT1 antibody at 1 ug/mL in (A) the absence and (B) the presence of blocking peptide.
Immunohistochemistry of DPAGT1 in human kidney tissue with DPAGT1 antibody at 2.5 ug/mL.
Immunofluorescence of DPAGT1 in human kidney tissue with DPAGT1 antibody at 20 ug/mL.